Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

IDEXX LABORATORIES INC /DE Director's Dealing 2012

Feb 16, 2012

30016_dirs_2012-02-16_f10ed56b-0660-4ba2-8ff8-d6688d8cb2d9.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: IDEXX LABORATORIES INC /DE (IDXX)
CIK: 0000874716
Period of Report: 2012-02-14

Reporting Person: RAINES MERILEE (CORPORATE VP & CFO)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2012-02-14 Common Stock M 306 Acquired 169970 Direct
2012-02-14 Common Stock M 422 Acquired 170392 Direct
2012-02-14 Common Stock M 436 Acquired 170828 Direct
2012-02-14 Common Stock M 386 Acquired 171214 Direct
2012-02-14 Common Stock M 476 Acquired 171690 Direct
2012-02-14 Common Stock F 669 $87.42 Disposed 171021 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2012-02-14 Non-Qualified Stock Option (right to buy) $87.42 A 12373 Acquired 2019-02-13 Common Stock (12373) Direct
2012-02-14 Incentive Stock Option (right to buy) $87.42 A 1143 Acquired 2019-02-13 Common Stock (1143) Direct
2012-02-14 Restricted Stock Unit $ A 1358 Acquired Common Stock (1358) Direct
2012-02-14 Restricted Stock Unit $ M 306 Disposed Common Stock (306) Direct
2012-02-14 Restricted Stock Unit $ M 422 Disposed Common Stock (422) Direct
2012-02-14 Restricted Stock Unit $ M 436 Disposed Common Stock (436) Direct
2012-02-14 Restricted Stock Unit $ M 386 Disposed Common Stock (386) Direct
2012-02-14 Restricted Stock Unit $ M 476 Disposed Common Stock (476) Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 13430 Indirect

Footnotes

F1: Excludes 13,430 shares previously owned directly, which were contributed to a Charitable Remainder Unitrust on 12/20/2011.

F2: Grant of options to buy shares of common stock becomes exercisable as to 2,704 shares on 02/14/2013, 2,703 shares 02/14/2014, 02/14/2015 and 02/14/2016, and the remaining 1,560 shares on 02/14/2017.

F3: Grant of options to buy shares of common stock that vest on the fifth anniversary date (02/14/2017) of the grant.

F4: Each restricted stock unit represents a contingent right to receive one share of IDEXX Laboratories, Inc. common stock. The restricted stock units vest in five equal annual installments, beginning on the first anniversary date (02/14/2013) of the date of grant.

F5: Each restricted stock unit represents a contingent right to receive one share of IDEXX Laboratories, Inc. common stock. The restricted stock units vest in five equal annual installments, beginning on the first anniversary date (02/14/2012) of the date of grant.

F6: Each restricted stock unit represents a contingent right to receive one share of IDEXX Laboratories, Inc. common stock. The restricted stock units vest in five equal annual installments, beginning on the first anniversary date (02/14/2011) of the date of grant.

F7: Each restricted stock unit represents a contingent right to receive one share of IDEXX Laboratories, Inc. common stock. The restricted stock units vest in five equal annual installments, beginning on the first anniversary date (02/14/2010) of the date of grant.

F8: Each restricted stock unit represents a contingent right to receive one share of IDEXX Laboratories, Inc. common stock. The restricted stock units vest in five equal annual installments, beginning on the first anniversary date (02/14/2009) of the date of grant.

F9: Each restricted stock unit represents a contingent right to receive one share of IDEXX Laboratories, Inc. common stock. The restricted stock units vest in five equal annual installments, beginning on the first anniversary date (02/14/2008) of the date of grant.